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Lith geneCompelling evidence has demonstrated that estrogen is a critical risk factor for gallstone formation and enhances
cholesterol cholelithogenesis through the hepatic estrogen receptorα (ERα), but not ERβ. To study the lithogenic
mechanisms of estrogen through ERα, we investigatedwhether the deletion of Erα protects against gallstone for-
mation in ovariectomized (OVX) female mice fed a lithogenic diet and treated with 17β-estradiol (E2) at 0 or 6
μg/day for 56 days. Our results showed that the prevalence of gallstones was reduced from 100% in OVX ERα
(+/+) mice to 30% in OVX ERα (−/−) mice in response to high doses of E2 and the lithogenic diet for
56 days. Hepatic cholesterol secretion was signiﬁcantly diminished in OVX ERα (−/−) mice compared to OVX
ERα (+/+) mice even fed the lithogenic diet and treated with E2 for 56 days. These alterations decreased bile
lithogenicity by reducing cholesterol saturation index of gallbladder bile. Immunohistochemical studies revealed
that ERα was expressed mainly in the gallbladder smooth muscle cells. High levels of E2 impaired gallbladder
emptying functionmostly through the ERα and cholecystokinin-1 receptor pathway, leading to gallbladder stasis
in OVX ERα (+/+) mice. By contrast, gallbladder emptying function was greatly improved in OVX ERα (−/−)
mice. This markedly retarded cholesterol crystallization and the growth and agglomeration of solid cholesterol
crystals into microlithiasis and stones. In conclusion, the deletion of Erα reduces susceptibility to the formation
of E2-induced gallstones by diminishing hepatic cholesterol secretion, desaturating gallbladder bile, and improv-
ing gallbladder contraction function in female mice.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Epidemiological and clinical studies have clearly shown that women
are twice as likely as men to suffer from cholesterol cholelithiasis at all
ages in every population investigated. This gender difference begins
since puberty and continues through the childbearing years. Most, but
not all, studies have found that the use of oral contraceptive steroids
and conjugated estrogens markedly increases cholelithogenesis in
premenopausal women, leading to hepatic cholesterol hypersecretion
and biliary lithogenicity [1–4]. Because plasma concentrations of female
sex hormones, especially estrogen, increase positively and linearly with
the duration of gestation, the risk of gallstone formation becomes higher
in the third trimester of pregnancy. Increasing parity is also a risk factor
for gallstones, especially in younger women. Notably, parity and length
of the fertility period increase the incidence of gallstones [5], as well aser); CCK, cholecystokinin; CSI,
gen receptor; ERα, ER subtype
tor 30; OVX, ovariectomized.
ine, Division of Gastroenterology
St. Louis, MO 63104, USA.both the number and frequency of pregnancy are important risk factors
for gallstone formation [6–10]. Thus, elevated estrogen levels are a
critical risk factor for the formation of cholesterol gallstones during
pregnancy. Moreover, biliary sludge (a precursor to gallstones) and
microlithiasis are observed to disappear spontaneously after parturition
in ~60%of casesmostly because of a signiﬁcant reduction in estrogen con-
centrations [11]. Similar lithogenic effects are also found during estrogen
therapy in postmenopausal women and inmenwith prostatic carcinoma
[12–16]. All of these ﬁndings underscore the importance of estrogen on
the pathogenesis of gallstones.
As found fromhuman and animal studies, high levels of estrogen en-
hance susceptibility to cholesterol cholelithiasis by promoting hepatic
hypersecretion of biliary cholesterol and increasing bile lithogenicity
[17–22]. Such alterations lead to a dramatic increment in cholesterol
saturation of bile, thereby increasing risk of developing gallstones [1,
23–25]. It has been established that estrogen plays a critical role in
enhancing cholelithogenesis by activating the hepatic estrogen receptor
α (ERα), but not ERβ [26]. While ERα is activated by E2, mice still keep
synthesizing cholesterol in the liver even though excess amounts of cho-
lesterol are available from a high-cholesterol diet. Thesemetabolic abnor-
malities indicate a disruption in the negative feedback regulation of
cholesterol synthesis in the liver, which is determined by an “estrogen-
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newly synthesized cholesterol available for biliary hypersecretion, thus
leading to cholesterol-supersaturated bile, as well as rapid cholesterol
crystallization and gallstone formation in mice treated with high doses
of E2 [26]. Based on these observations, a novel concept has been pro-
posed that estrogen enhances cholesterol cholelithogenesis through the
ERα signaling pathway in the liver and that higher risks for gallstone for-
mation inwomen than inmen are related to differences in howcholester-
ol is handled in the liver under conditions of high estrogen levels [28].
Because ERα has a crucial effect on the formation of E2-induced
cholesterol gallstones, in the current study, we studied whether the
targeted disruption of the Erα gene protects against the formation of
gallstones in mice treated with high doses of E2 and fed a lithogenic
diet for 56 days. Our results show that the susceptibility to E2-induced
cholesterol cholelithiasis is signiﬁcantly reduced through the ERα-
mediated pathways in the liver and gallbladder in ovariectomized
(OVX) ERα (−/−) mice even treated with E2 and fed the lithogenic
diet for 56 days.
2. Materials and methods
2.1. Animals and diets
The inbred AKR/J mice of both genders from the Jackson Laboratory
(Bar Harbor, ME) were bred to generate female mice for the studies.
Although AKR/J mice are a gallstone-resistant strain, they are still sus-
ceptible to estrogen-induced cholesterol gallstones [26]. AKR/J mice
have intact expression of the Erα and Erβ genes; however, expression
levels of Erβ are 50-fold lower than those of Erα in the liver [26]. Thus,
the AKR/J strain was used as control mice, i.e., ERα (+/+) mice. The
ERα (+/−) mice of both genders on a C57BL/6 J genetic background
(the Jackson Laboratory) were crossed with AKR/J mice for ten genera-
tions to produce a new strain of ERα (+/−) mice on an AKR/J genetic
background. We have established breeding colonies of these mice in-
house. Of note, ERα (+/−) heterozygotes are healthy and fertile, and
they exhibit no obvious phenotypes in association with the disrupted
Erα genotype. A cross between heterozygous ERα (+/−) mice resulted
in the live birth of normal litter sizes of homozygous ERα (−/−) mice.
To exclude possible interindividual differences in endogenous
estrogen concentrations, at 4 weeks of age, all female mice were ovari-
ectomized (OVX). At 8 weeks of age, the mice were implanted subcuta-
neously with pellets releasing E2 at 0 or 6 μg/day for 56 days (Innovative
Research of America, Sarasota, FL) according to our published methods
[26]. All animals were maintained in a temperature-controlled room
(22±1 °C)with a 12-hour day cycle (0600 h–1800 h) andwere provid-
ed free access to water and normal mouse chow containing trace
cholesterol (b0.02%) (Lab Rodent Diet, St. Louis, MO). For gallstone
studies, mice at 8 weeks old were fed a lithogenic diet containing 1%
cholesterol, 15% butter fat, and 0.5% cholic acid for 56 days. All proce-
dures were in accordance with current NIH guidelines and were ap-
proved by the Institutional Animal Care and Use Committee of Saint
Louis University (St. Louis, MO).
2.2. Microscopic studies of gallbladder bile and gallstones
After anesthetization with pentobarbital, a cholecystectomy was
performed on fasted mice. Gallbladder bile was collected before (day
0, on chow) and at frequent intervals after feeding the lithogenic diet
for 3, 6, 9, and 12 days for cholesterol crystallization studies (n = 5
per group for each time point), as well as for 56 days for gallstone stud-
ies (n=20 per group). The entire gallbladder bile was studied by phase
contrast and polarized light microscopy for observing the presence of
mucin gel, liquid crystals, solid cholesterol crystals, sandy stones, and
gallstones [29]. The images of cholesterol monohydrate crystals and
gallstones were analyzed by a Carl Zeiss Imaging System with an Axio-
Vision Rel 4.6 software (Carl Zeiss Microimaging GmbH, Göttingen,Germany). After microscopic analysis, gallbladder bile was frozen and
stored at−20 °C for lipid analyses.
2.3. Measurement of biliary lipid output
During laparotomy, the common bile duct was cannulated with a
PE-10 polyethylene catheter. After successful catheterization and ﬂow
of ﬁstula bile, cholecystectomy was performed. The ﬁrst hour sample
of hepatic bile was collected by gravity in mice (n = 5 per group)
[30]. Subsequently, hepatic bile was examined by polarizing light
microscopy and the volume of each bile sample was measured. During
surgery and hepatic bile collection, mouse body temperature was kept
at 37± 0.5 °C with a heating lamp andmonitored with a thermometer.
All bile samples were frozen and stored at −20 °C for further lipid
studies.
2.4. Dynamic measurement of gallbladder emptying function
To explore whether the activation of ERα by E2 impairs gallbladder
contractility, a dynamic measurement of gallbladder motility function
was performed inmice in response to a high-fatmeal or to exogenously
administered sulfated cholecystokinin octapeptide (CCK-8) at 56 days
on the lithogenic diet [31]. After mice (n = 5 per group) were fasted
overnight but had free access to water, they were anesthetized with
pentobarbital. During laparotomy, a PE-10 catheter was inserted into
the duodenum. It was externalized through the left abdominal wall
and connected to an infusion pump for infusing corn oil. The right jugu-
lar veinwas cannulatedwith a PE-10 catheter for intravenous CCK-8 in-
jection. After all surgical procedures were completed, the gallbladder
was clearly exposed and its volume was measured with a micro-
caliper according to previously published methods [31].
After the ﬁrst group of mice was intraduodenally infused with corn
oil (i.e., a high-fat meal) or 0.9% NaCl (as a control) at 40 μL/min for
5 min, postprandial gallbladder volume was determined at 30 min
after the infusion. The second group of mice was intravenously injected
through the jugular veinwith exactly 17 nmol/kg bodyweight of CCK-8
dissolved in 100 μL of phosphate buffered saline (PBS) solution, or
100 μL of only PBS solution (as a control). Following that, gallbladder
volume was measured every 10 min for 30 min. Gallbladder emptying
rate was determined by a difference in gallbladder size before and
after the duodenal infusion of corn oil or the intravenous injection of
CCK-8.
2.5. Biliary lipid analysis
Biliary phospholipids were determined as inorganic phosphorus by
the method of Bartlett [32]. Biliary cholesterol was measured using an
enzymatic assay [33]. Total bile salt concentration was enzymatically
determined by the 3α-hydroxysteroid dehydrogenase method [34]. In-
dividual bile salt species were analyzed by high-performance liquid
chromatography (HPLC) [35] and hydrophobicity index of bile samples
was calculated according to Heuman's method [36]. Cholesterol satura-
tion index (CSI) of pooled gallbladder bile was calculated from critical
tables [37]. Relative lipid composition of pooled gallbladder bile was
plotted on a condensed phased diagram. For graphic analysis, the
phase limits of the micellar zone and the crystallization pathways
were extrapolated frommodel bile systems developed for taurocholate
at 37 °C and at a total lipid concentration of 9 g/dL [38].
2.6. Immunohistochemical staining
The blocks of parafﬁn-embedded gallbladder tissues were cut at
4-μm thickness, dewaxed, and rehydrated. For ERα staining, antigen
retrieval was carried out by boiling in 10 mM citrate buffer (pH 7.0)
for 1 min. All the staining processes were performed by using
Histostain Plus 3rd Gen IHC Detection Kit according to the
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were incubatedwith anti-ERα antibody (Santa Cruz, Dallas, TX) at a dilu-
tion of 1:100. The primary antibodywas replaced by the blocking solution
containing 10% non-immune goat serum for negative control slides. After
washing, the sections were incubated with the corresponding secondary
antibody for 30 min at room temperature. Subsequently, the sections
were counterstained with hematoxylin, dehydrated through an alcohol
series to xylene, and mounted.2.7. Quantitative real-time PCR assay
Total RNA was extracted from mouse liver and gallbladder tissues
(n = 4 per group) using RNeasy Midi (Qiagen, Valencia, CA). Reverse-
transcription reaction was performed using the iScript Reverse Tran-
scription Supermix for RT-qPCR (Bio-Rad, Hercules, CA) with 1 μg of
total RNA and random hexamers to generate cDNA. Quantitative real-
time PCR assays were performed in triplicate for the Erα gene and the
genes involved in the regulation of hepatic lipid metabolism, including
ATP-binding cassette transporter G5 (Abcg5), Abcg8, Abcb4, Abcb11,
cholesterol 7α-hydroxylase (Cyp7a1), sterol 27-hydroxylase (Cyp27a1),
acyl-CoA:cholesterol acyltransferase, isoform 2 (Acat2), sterol-regulatory
element binding protein-2 (Srebp-2), 3-hydroxy-3-methylglutaryl coen-
zyme A (HMG-CoA) reductase (Hmgcr), farnesyl diphosphate synthase
(Fdps), lathosterol synthase (Lss), squalene synthase (Sqs), HMG-CoA syn-
thase, isoform 1 (Hmgcs1), Hmgcs2, and low-density lipoprotein receptor
(Ldlr), as well as for gallbladder Erα, cholecystokinin-1 receptor (Cck-1r),
Acat2, Abcg5, Abcg8, and Niemann-Pick C1-like 1 (Npc1l1). The sequences
of the primers for these genes are listed in Table 1. Relative mRNA levels
were calculated using the threshold cycle of an unknown sample against
a standard curve with known copy numbers. To obtain a normalized tar-
get value, the target amount was divided by the endogenous reference
amount of mouse β-actin as internal control.2.8. Statistical method
All data are expressed as means ± SD. Statistically signiﬁcant differ-
ences among groups of mice were assessed by Student's t-test, Mann–
Whitney U-tests, or Chi-square tests. If the F-valuewas signiﬁcant, com-
parisons among groups of mice were further analyzed by a multiple
comparison test. Analyses were performed with SuperANOVA software
(Abacus Concepts, Berkeley, CA). Statistical signiﬁcance was deﬁned as
a two-tailed probability of less than 0.05.Table 1
Primer and probe sequences in mRNA quantiﬁcation by real-time PCR.
Gene Accession number Forward Reverse
Abca1 AK019548 5′-TTGAAATCTCTCGGATACAATCGA-3′ 5′-AAGCC
Abcb4 NM_008830 5′-GGAAATCATTGGTGTGGTAAGTCA-3′ 5′-CACGG
Abcb11 NM_021022 5′-TCTGGTACGGCTCCAGACTTG-3′ 5′-GCTGC
Abcg5 AF312713 5′-CCTGCAGAGCGACGTTTTTC-3′ 5′-GCATC
Abcg8 AF324495 5′-TGGATAGTGCCTGCATGGATC-3′ 5′-AATTG
Acat2 AF078751 5′-TTTGCTCTATGCCTGCTTCATC-3′ 5′-GGTTC
Cck-1r NM_009827 5′-CAACCTGCTCAAGGATTTCATCT-3′ 5′-CACGG
Cyp7a1 NM_007824 5′-TCGTGATCCTCTGGGCATCT-3′ 5′-CCAAG
Cyp27a1 NM_024264 5′-TGACATGGGCCCTGTACCA-3′ 5′-TCCCAG
Erα NM_007956 5′-CCAGCAGTAACGAGAAAGGAAAC-3′ 5′-TCATTG
Fdps BC048497 5′-CGGGCAGACTCTAGACCTCATG-3′ 5′-CGATT
Hmgcr M62766 5′-ATTCTGGCAGTCAGTGGGAACT-3′ 5′-CCTCGT
Hmgcs1 NM_145942 5′-CCACAGGAAATGCCAGACCTA-3′ 5′-GGAGC
Hmgcs2 NM_008256 5′-TACCTGCGGGCCTTGGAT-3′ 5′-GGTGA
Ldlr NM_010700 5′-GCTCCATAGGCTATCTGCTCTTCA-3′ 5′-TGCGG
Lss NM_146006 5′-GCACACCACAGACCTGAGTTTC-3′ 5′-GGACA
Sqs NM_010191 5′-GGAAGTGTTAATCCGTGTTGTTCTG-3′ 5′-GCTCCC
Srebp2 AF374267 5′-TGAAGCTGGCCAATCAGAAAA-3′ 5′-CCACA
β-Actin NM_007393 5′-GCTCTGGCTCCTAGCACCAT-3′ 5′-GCCAC
See text for abbreviations.3. Results
3.1. Prevalence and characteristic of gallstones
Fig. 1A shows representative photomicrographs of amorphous
mucin gel, liquid crystals, solid cholesterol crystals, and gallstones as ob-
served by polarizing light microscopy in gallbladder bile of OVX ERα
(+/+) and (−/−) mice. At 56 day on the lithogenic diet, gallbladders
of OVX ERα (+/+) mice formed a thick layer of sticky mucin gel
(100%) interspersedwith solid plate-like cholesterolmonohydrate crys-
tals (90%) and aggregated and fused liquid crystals (50%). In contrast,
gallbladders of OVX ERα (−/−) mice contained a thin layer of mucin
gel (100%), aggregated and fused liquid crystals (60%), and cholesterol
monohydrate crystals (30%). As shown in Fig. 1B, gallstone prevalence
in OVX ERα (+/+) mice (100%) is signiﬁcantly higher than that in
OVX ERα (−/−) mice (30%). Assessment of gallstone frequency in
OVX ERα (+/+) mice found that the number distribution fell between
1 and 3 in 50% of themice and between 4 and 6 in 40% of themice, while
10% of themice formedmore than 10 stones.Moreover, 20% of OVX ERα
(−/−) mice had 1–3 stones and 10% of them harbored 4–6 stones.
Of special note, 70% of OVX ERα (−/−) did not have gallstones in the
gallbladder.3.2. Lipid composition and CSI values of gallbladder bile
Table 2 lists relative biliary lipid composition of pooled gallbladder
bile in mice fed chow (day 0) and the lithogenic diet at different time
points. At 6 days on the lithogenic diet, the CSI value reached supersat-
urated inOVX ERα (+/+)mice. By contrast, gallbladder bile was unsat-
urated at 6 days in OVX ERα (−/−) mice. Fig. 1C shows that during the
56-day period of the lithogenic diet feeding, relative lipid composition
of gallbladder bile gradually moves upward and to the right of the
phase diagram in both OVX ERα (+/+) and (−/−)mice. Such a change
was induced by a relative increase in cholesterol and phospholipid con-
centrations and relatively unchanged bile salt concentrations. Because
relative lipid composition of bile passed through crystallization region
B in OVX ERα (+/+) mice between 6 and 12 days on the lithogenic
diet, tubular crystals (i.e., anhydrous cholesterol crystals) were found
ﬁrst, followed by classical plate-like cholesterol monohydrate crystals
(Fig. 1A). By contrast, relative lipid composition of bile in OVX ERα
(−/−) mice directly entered crystallization region C from the micellar
zone during lithogenesis. In the region C, liquid crystals always ap-
peared before cholesterol monohydrate crystals.Probe
CATTGTTTGCCCAT-3′ 5′-CGTCTGACCTTTGGGATCCTCACCA-3′
CCATAGCGGATATTTT-3′ 5′-AGCCCGTGCTGTTCTCTACTACGATCGC-3′
TATTATGACACAGAGGAAAAT-3′ 5′-AAGGCGAGTACACACCAGGGACACTGATC-3′
GCTGTGTATCGCAAC-3′ 5′-AGCAGCCTCACTGTGCGCGAGA-3′
AATCTGCATCAGCCCC-3′ 5′-CAAGCTGTCGTTCCTCCGGTGGTG-3′
CCGGCTCATGTTG-3′ 5′-TGGGCCGCCTCTGTGTCCCT-3′
AAGTGCCCATGAAGT-3′ 5′-CGGAAGTGCCGTGTGCAAGACTACC-3′
TGCATTAACTGTGGGTAAA-3′ 5′-AGGAGGCTCTGCGGCTCTCC-3′
GGTTATCAGCCTCTT-3′ 5′-CAGAGATCCAGGAGGCCTTGCAC-3′
CACACGGCACAGT-3′ 5′-TCATGGAGTCTGCCAAGGAGACTCGC-3′
TGTACCTCTTTTCAGTGTATCTAC-3′ 5′-AGCACCCCAGGGCCATGTGGA-3′
CCTTCGATCCAATTT-3′ 5′-CACCGACAAGAAGCCTGCTGCCA-3′
GTTTGGCCCAATTA-3′ 5′-AGGTGGAGTTGGAGCTGTGGCCCT-3′
AAGGCTGGTTGTTTCC-3′ 5′-ATGCTATGCAGCCTACCGCAAGAAGATCC-3′
TCCAGGGTCATCT-3′ 5′-CAACCGCCACGAGGTCCGG-3′
GTTTTCTGGAACCTGTGA-3′ 5′-CTGCAGAAGGCTCACGAGTTCCTGC-3′
CCTGGGTGAGA-3′ 5′-TGTGAGCTCCCGAGACTGCAGGCT-3′
TCACTGTCCACCAGACT-3′ 5′-CAAGCTCCTGAAGGGCATCGACCTG-3′
CATCCACACAGAGT-3′ 5′-AAGATCATTGCTCCTCCTGAGCGCAA-3′
Fig. 1. (A) Representative photomicrographs of cholesterol crystallization and gallstone formation as observed by polarizing light microscopy in gallbladder bile of E2-treated OVX ERα (+/+)
and (−/−) mice during the 56-day period of the lithogenic diet feeding: (a and b) non-birefringent amorphousmucin gel; (c) tubular (possible anhydrous cholesterol) crystal; (d) numerous
non-birefringent aggregated liquid crystals and few fused liquid crystals withinmucin gel; (e and f) agglomerates of typical cholesterolmonohydrate crystals, with 79.2° and 100.8° angles, and
often a notched corner; and (g and h) gallstones displaying rounded contours and black centers from light scattering/absorption. All magniﬁcations are ×800 except for far right two panels
× 200. (B) At 56 day on the lithogenic diet, the prevalence of gallstones is 100% in OVX ERα (+/+)mice, being signiﬁcantly (P b 0.05) higher than that (30%) in OVX ERα (−/−) mice treated
with E2 at 6 μg/day. (C) The relative lipid composition of pooled gallbladder bile fromOVXERα (+/+) and (−/−)mice at each timepoint (see Table 2) is plottedona condensedphase diagram.
The one-phasemicellar zone at the bottom is enclosed by a solid curved line. Above themicellar zone, two solid lines divide the two-phase zones from a central three-phase zone, showing ﬁve
cholesterol crystallization pathways A to E. Symbols● represent OVX ERα (+/+) mice and ■ for OVX ERα (−/−) mice.
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by HPLC, OVX ERα (+/+) and (−/−) mice showed similar distribu-
tions of the molecular species of bile salts. Moreover, all bile salts were
taurine conjugated. Because 0.5% cholic acid in the lithogenic diet was
fed to mice, taurocholate became the major bile salt (54.8 ± 5.0% in
ERα (+/+) mice vs 50.5 ± 6.3% in ERα (−/−) mice), followed byTable 2
Biliary lipid composition of gallbladder bile during gallstone formation.
Day Ch
(mM)
PL
(mM)
BS
(mM)
Ch/PL
Ratio
Ch/BS
Ratio
[TL]
(g/dL)
CSI
ERα (+/+)
0 4.24 19.73 147.56 0.215 0.029 8.94 0.56
3 5.50 21.25 140.79 0.259 0.039 8.77 0.70
6 9.08 24.02 147.34 0.378 0.062 9.45 1.01
9 10.28 27.14 141.76 0.379 0.073 9.46 1.05
12 12.68 30.20 142.79 0.420 0.089 9.84 1.17
56 16.23 33.16 141.25 0.489 0.115 10.13 1.37
ERα (−/−)
0 3.17 18.14 148.51 0.175 0.021 8.82 0.44
3 4.32 22.13 143.82 0.195 0.030 8.94 0.53
6 5.89 21.87 138.65 0.269 0.042 8.73 0.73
9 8.36 24.35 118.68 0.343 0.070 8.04 1.00
12 11.04 30.12 144.71 0.367 0.076 9.84 1.02
56 14.61 32.14 142.83 0.455 0.102 10.07 1.27
Values were determined from pooled gallbladder bile (n = 5 per group).
Abbreviation: BS, bile salts; Ch, cholesterol; CSI, cholesterol saturation index; PL, phospho-
lipids; [TL], total lipid concentration.diminished proportions of taurochenodeoxycholate (24.5 ± 4.3% vs
32.4 ± 7.3%) and taurodeoxycholate (9.6 ± 1.6% vs 8.5 ± 1.1%). Low
concentrations of tauro-β-muricholate (5.3 ± 0.9% vs 4.5 ± 0.4%),
tauroursodeoxycholate (4.9 ± 2.3% vs 3.2 ± 0.7%), and tauro-
ω-muricholate (0.9 ± 0.2% vs 0.9 ± 0.3%) were also found in two
groups of mice. Hydrophobicity indexes of gallbladder bile speci-
mens (0.10 ± 0.03 vs 0.14 ± 0.03) were comparable between OVX
ERα (+/+) and (−/−) mice.
3.3. Biliary lipid output and bile ﬂow
Fig. 2 exhibits biliary lipid output in OVX ERα (+/+) and (−/−)
mice during the ﬁrst hour after interruption of the enterohepatic circu-
lation. Biliary cholesterol and phospholipid output was signiﬁcantly
lower in OVX ERα (−/−) mice (10.9 ± 2.7 μmol/h/kg and 35.8 ± 7.5
μmol/h/kg) than in OVX ERα (+/+) mice (24.6 ± 8.0 μmol/h/kg and
58.6 ± 11.0 μmol/h/kg). Biliary bile acid output was also reduced in
OVX ERα (−/−) mice (217.0 ± 69.6 μmol/h/kg) than in OVX ERα
(+/+)mice (279.7± 59.9 μmol/h/kg), but a signiﬁcantly statistical dif-
ference was not appreciated. The ratios of cholesterol/phospholipid and
cholesterol/bile salts were signiﬁcantly reduced in OVX ERα (−/−)
mice than those in OVX ERα (+/+)mice, indicating that bile cholester-
ol saturation was signiﬁcantly lower in the former than in the latter. At
56 days on the lithogenic diet, bile ﬂow rate was determined during the
ﬁrst hour of hepatic bile collection, thus avoiding appreciable perturba-
tion of the enterohepatic circulation of bile salts. Bile ﬂow rates were
comparable between OVX ERα (+/+) and (−/−) mice.
Fig. 2. Hepatic output of (A) biliary cholesterol, (B) phospholipids, and (C) bile salts, as
well as (D) the ratios of Ch/PL and (E) Ch/BS, and (F) bile ﬂow rates during the ﬁrst
hour of biliary secretion in OVX ERα (+/+) and (−/−) mice treated with E2 at 6 μg/day
and fed the lithogenic diet for 56 days. *P b 0.01 and **P b 0.05, compared with OVX ERα
(+/+) mice. Abbreviations: Ch, cholesterol; PL, phospholipids; BS, bile salts.
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metabolism in the liver
In Fig. 3, we focused mainly on the comparison of mRNA levels of
these genes between OVX ERα (+/+) and (−/−) mice treated with
E2 at 0 or 6 μg/day and fed the lithogenic diet for 56 days. Of special
note is that no signiﬁcant differences in expression of these genes
were found between OVX ERα (+/+) and (−/−) mice receiving no
E2 and fed the lithogenic diet for 56 days.
It has been reported that E2 binds with high afﬁnity to ERα and
regulates its expression. Compared to OVX ERα (+/+) mice receiving
no E2, hepatic expression of the Erα gene signiﬁcantly increased in
OVX ERα (+/+) mice. As expected, expression of Erα in the liver was
not detected in OVX ERα (−/−) mice, regardless of whether or not
these mice were treated with E2 for 56 days.
In the lithogenic state, E2 signiﬁcantly increased hepatic expression
of Abcg5 and Abcg8 in OVX ERα (+/+) mice compared to OVX ERα
(+/+) mice receiving no E2. However, mRNA levels of Abcg5/g8 were
signiﬁcantly reduced in OVX ERα (−/−) mice compared to those in
OVX ERα (+/+) mice. Moreover, changes in hepatic expression of
Abcb4 and Abcb11 displayed the same trend as that of Abcg5/g8 for
OVX ERα (+/+) and (−/−) mice. It has been recognized that ABCG5/
G8, ABCB4, and ABCB11 are the transporters on the canalicular mem-
brane of hepatocytes for hepatic secretion of biliary cholesterol,
phospholipids, and bile salts, respectively. Furthermore, CYP7A1
and CYP27A1 are two rate-limiting enzymes regulating the classical and
the alternative pathways of bile salt synthesis in the liver. Hepatic expres-
sion of Cyp7a1, but not Cyp27a1 was signiﬁcantly reduced only in OVX
ERα (−/−) mice. At 56 days on the lithogenic diet, expression of Srebp2
and Ldlr was signiﬁcantly increased in OVX ERα (+/+), but not (−/−)
mice compared to those in OVX ERα (+/+) mice receiving no E2.
Moreover, mRNA levels of Hmgcs1, Hmgcs2, Hmgcr, Fdps, Sqs, and
Lss, which are involved in cholesterol synthesis, were signiﬁcantly
higher in OVX ERα (+/+) mice than in OVX ERα (−/−) mice.Notably, hepatic expression of Acat2 remained the same in these
groups of OVX mice.
3.5. Effect of E2 on gallbladder contract function
Fig. 4A shows fasting gallbladder volumes as functions of days on the
lithogenic diet for 56 days. At day 0 on chow, fasting gallbladder vol-
umes were basically the same between OVX ERα (+/+) and (−/−)
mice. However, after 3 days on the lithogenic diet, the gallbladder vol-
ume began to increase in OVX ERα (+/+) mice and this persisted
thereafter. Obviously, this increase in gallbladder volumes paralleled
an increment of CSI values in bile. Overall, in the lithogenic state, gall-
bladder volumes were dramatically enlarged in OVX ERα (+/+) mice
compared to those in OVX ERα (−/−) mice. Fig. 4B shows changes in
postprandial residual gallbladder volumes in response to the fatty
meal at 56 days on the lithogenic diet. Notably, a signiﬁcant portion of
gallbladder bile was emptied out in OVX ERα (−/−), but not (+/+)
mice. Postprandial residual gallbladder volumes were signiﬁcantly larg-
er in OVX ERα (+/+) mice compared to OVX ERα (−/−) mice. These
results showed that gallbladder emptying function was impaired in
E2-treated OVX ERα (+/+) mice.
Fig. 5A, exhibits that gallbladder emptying rate is reduced in OVX
ERα (+/+) mice in response to intravenous administration of CCK-8.
In contrast, a large portion of gallbladder bile was excreted in OVX
ERα (−/−) mice. As a result, at 30 min after CCK-8 administration, re-
sidual gallbladder volumes were signiﬁcantly smaller in OVX ERα
(−/−)mice than inOVXERα (+/+)mice. Furthermore, the concentra-
tions of cholesterol and cholesteryl esters in the gallbladder wall were
signiﬁcantly lower in the former than in the latter (Fig. 5B). Of special
note, at 56 days of E2 treatment and feeding the lithogenic diet, mRNA
levels of Cck-1r in the gallbladder were signiﬁcantly lower in OVX ERα
(+/+) mice than in OVX ERα (−/−) mice (Fig. 5C). The mRNA levels
of Npc1l1, Abcg5 and Abcg8 (the gallbladder lipid transporters) and
Acat2 (for cholesterol esteriﬁcation) in the gallbladder were signiﬁcant-
ly higher in OVX ERα (+/+)mice than those in OVX ERα (−/−) mice.
High expression of Abcg5 and Abcg8 in OVX ERα (+/+) mice may be
secondary to increased accumulation of cholesterol in the gallbladder.
3.6. Expression of ERα in the gallbladder by immunohistochemistry
As shown in Fig. 6, ERα is expressed predominately in the gallblad-
der smooth muscle cells by immunohistochemical staining in chow-
fed female ERα (+/+)micewith intact ovaries. In contrast, the expres-
sion of ERαwas not detected in the gallbladder in chow-fed female ERα
(−/−) mice with intact ovaries (data not shown).
4. Discussion
A large number of human and animal studies have found that E2
plays a critical role in promoting cholesterol gallstone formation.
Although E2 has a crucial effect on the transcriptional modulation of tar-
get genes through two classical ERs (i.e., ERα and ERβ), ERα is the key
steroid hormone receptor exerting the biological effect of E2 in the
liver [26]. The important ﬁndings of the present study are summarized
as follows: (i) the targeted disruption of the Erα gene reduces suscepti-
bility to E2-induced gallstones by diminishing hepatic synthesis and bil-
iary secretion of cholesterol, thus desaturating bile and reducing CSI
values; and (ii) the deletion of the Erα gene prevents the inhibitory ef-
fect of E2 on gallbladder emptying function mostly through the ERα
and CCK-1R pathway, thereby deterring cholesterol crystallization
and the growth and agglomeration of solid cholesterol crystals
into microlithiasis and macroscopic stones.
One of the mechanisms underlying the lithogenic effect of E2 on
hepatic cholesterol hypersecretion is that the activity of HMG-CoA
reductase, the rate-limiting enzyme in hepatic cholesterol synthesis, is
increased, leading to excess amount of cholesterol from hepatic de
Fig. 3. Effect of E2 onmRNA levels of the genes involved in the regulation of hepatic lipidmetabolism. ThemRNA levels of genes inOVXERα (+/+)and (−/−)mice receiving noE2 and fed
the lithogenic diet for 56 days are set at 1. Notably, there are no signiﬁcant differences in expression of these genes betweenOVX ERα (+/+) and (−/−)mice receiving noE2. *P b 0.01 and
**P b 0.05, compared to OVX ERα (+/+) mice treated with E2 at 6 μg/day and fed the lithogenic diet for 56 days. See text for further description and the Materials and Methods for
abbreviations.
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that the high-cholesterol diet inhibits hepatic cholesterol synthesis by
a negative feedback regulation pathway through the SREBP-2 signaling
cascade. However, even under a high-cholesterol diet, expression of
Srebp-2 and the SREBP-2-responsive genes is still signiﬁcantly higher
in E2-treated OVX ERα (+/+) mice. These ﬁndings indicate an
“E2-ERα-SREBP-2” pathway for enhancing cholesterol synthesis in the
liver [27]. Therefore, in the face of high E2 levels, there is a continuous
cholesterol synthesis in the liver because the negative feedback regula-
tion of its synthesis determined by the SREBP-2 signaling pathway is
interrupted by E2 through the hepatic ERα [27]. In addition, E2 increases
the delivery of intestinal cholesterol to the liver for biliary hypersecre-
tion by promoting intestinal cholesterol absorption mostly through
the intestinal ERα [1,41]. These metabolic abnormalities in the liver
and small intestine lead to hepatic cholesterol hypersecretion and
supersaturated gallbladder bile that predisposes to rapid cholesterol
crystallization and precipitation of solid cholesterol monohydrate crys-
tals. Our published results have shown that the activation of ERα by E2
enhances hepatic cholesterogensis in OVX ERα (+/+)mice, regardlessof whether the chow or the high (1%) cholesterol diet is fed [27]. In the
current study, we found that hepatic cholesterol output and CSI values
are signiﬁcantly reduced in OVX ERα (−/−) mice compared to OVX
ERα (+/+)mice even in response to high doses of E2 and the lithogenic
diet. These results indicate that ERα is crucial to the negative feedback
regulation of cholesterol synthesis in the liver and plays a key role in
connecting E2 with the SREBP-2 signaling cascade for regulating choles-
terol synthesis. Furthermore, our ﬁndings, for the ﬁrst time, show the
importance of newly-synthesized cholesterol as a key source for hepatic
hypersecretion in E2-treated OVX ERα (+/+) mice.
The Abcg5/g8 has already been identiﬁed as a candidate gene in
the mouse Lith9 locus by quantitative trait locus (QTL) linkage analysis
[42]. Subsequently, the ABCG5/G8 gene was proved to be associated
with gallstones in patients (i.e., human LITH9) [43]. Moreover, two
gallstone-associated variants in ABCG5/G8 (ABCG5-R50C and ABCG8-
D19H) were identiﬁed not only in Germans and Chileans, but also in
Chinese and Indians [43–48]. We found that expression of Abcg5/g8 in
the liver is signiﬁcantly increased in E2-treated OVX ERα (+/+) mice,
coupled with hepatic hypersecretion of biliary cholesterol. In contrast,
Fig. 4. (A) Fasting gallbladder volumes as functions of time on the lithogenic diet and
(B) postprandial gallbladder volumes in response to a fatty meal in E2-treated OVX ERα
(+/+) and (−/−) mice fed the lithogenic diet for 56 days. *P b 0.01 and **P b 0.05,
compared to OVX ERα (+/+) mice treated with E2 at 6 μg/day and fed the lithogenic
diet for 56 days.
Fig. 5. (A) Gallbladder emptying rates in response to an exogenous CCK-8 stimulation;
(B) the concentrations of cholesterol and cholesteryl esters in gallbladder tissues; and
(C) mRNA levels of the genes encoding gallbladder lipid transporters and involved in
the regulation of lipid metabolism in OVX ERα (+/+) and (−/−) mice treated with
E2 at 6 μg/day and fed the lithogenic diet for 56 days. The experimental conditions are
the same as described in Fig. 3. *P b 0.01 and #P b 0.001, compared with PBS solution, or
OVX ERα (+/+) mice treated with E2 at 6 μg/day and fed the lithogenic diet for 56 days.
Fig. 6. Immunohistochemical studies reveal that ERα is expressed mainly in the gallbladder
smoothmuscle cells in chow-fed female ERα (+/+)mice with intact ovaries. All magniﬁca-
tions are ×400.
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Abcg5/g8 so that biliary cholesterol secretion is signiﬁcantly reduced in
E2-treated OVX ERα (−/−) mice even fed the lithogenic diet for
56 days. This shows that the activation of ERα by E2 has a role in the
transcriptional regulation of Abcg5/g8, thus inﬂuencing hepatic secre-
tion of biliary cholesterol. We also observed that expression of Abcb4
was reduced in E2-treated OVX ERα (−/−)mice, coupledwith a dimin-
ished hepatic output of biliary phospholipids. This shows that ERα acti-
vated by E2 may stimulate ABCB4 for regulating biliary phospholipid
secretion.
It is widely appreciated that the gallbladder also plays a pivotal role
in the pathogenesis of gallstones [49]. However, themechanisms under-
lying the lithogenic effect of E2 on impairing gallbladder motility
function are not fully understood. Clinically, real-time ultrasonography
has found that fasting gallbladder volumes and postprandial residual
volumes are increased by two-fold in women after the ﬁrst trimester
of pregnancy compared to control healthy subjects, a condition pointing
to gallbladder stasis [50]. In early pregnancy, there is a 30% decrease in
gallbladder emptying rate, and in late pregnancy, incomplete gallblad-
der emptying leads to a large residual volume that causes biliary sludge
and the retention of solid cholesterol crystals [25]. Gallbladder stasis
progresses during the ﬁrst 20 weeks of pregnancy and its severity is di-
rectly related to the duration of gestation. Gallbladder volumes quickly
return to control values after delivery [12]. However, it is still unclear
whether high levels of E2 are involved in gallbladder stasis through ERα.
In the present study, we observed that ERα is expressed mainly in
the gallbladder smooth muscle cells by immunohistochemical staining.
Moreover, fasting gallbladder volumes are increased and postprandialgallbladder emptying rates are reduced in OVX ERα (+/+) mice in re-
sponse to the high-fat diet. Gallbladder volumes are comparable before
and after exogenous CCK-8 stimulation in E2-treated OVX ERα (+/+)
mice, indicating that gallbladder contractility is impaired. In contrast,
the deletion of Erα protects against the inhibitory effect of E2 on gallblad-
der contraction function because CCK-8 administration signiﬁcantly leads
to almost complete gallbladder emptying in OVX ERα (−/−) mice even
Fig. 7. Proposed model for a critical role of ERα in E2-induced cholesterol gallstones. In the liver, E2 activation of ERα interferes with the negative feedback regulation (as shown by the
dashed line) of cholesterol synthesis by stimulating Srebp-2, with the resulting up-regulation of the SREBP-2-responsive genes for cholesterol synthesis. In addition, ERα increases expres-
sion of Abcg5/g8 and Ldlr in the liver through the transcriptional regulation. As a result, hepatic cholesterol secretion is signiﬁcantly increased, thus leading to supersaturation of bile. In the
gallbladder, ERα activated by E2 impairs gallbladder emptying function through the Cck-1r pathway, inducing bile stasis and accumulation of mucin gel in the gallbladder lumen. All of
these changes promote cholesterol crystallization and solid cholesterol crystal growth and agglomeration into microlithiasis and stones. Of special note is that the deletion of the Erα
gene reduces susceptibility to E2-induced cholesterol cholelithiasis in female mice.
2168 O. de Bari et al. / Biochimica et Biophysica Acta 1852 (2015) 2161–2169treated with E2. It is highly likely that the activation of ERα by E2 impairs
gallbladder emptying function by inhibiting expression of Cck-1r in the
gallbladder, or interrupting the binding of CCK-8 to CCK-1R, or both. In
addition, we observed that the concentrations of cholesterol and
cholesteryl esters in the gallbladder tissues are signiﬁcantly higher
in OVX ERα (+/+) mice compared to OVX ERα (−/−) mice. The
gallbladder epithelial cells have been found to actively modify biliary
lipid composition by absorbing and secreting biliary lipids [49]. When
bile is supersaturatedwith cholesterol, gallbladder cholesterol absorption
is enhanced, thus leading to the accumulation of excess cholesterol in the
gallbladderwall because gallbladder epithelial cells cannot assemble lipo-
proteins for lipid transport into plasma. In the lithogenic state, the
absorbed cholesterol has to be converted to cholesteryl esters and stored
in themucosa and lamina propria. As a result, the accumulation of excess
cholesterol in the gallbladder smoothmuscle cells could stiffen sarcolem-
mal membranes and decouple the G-protein-mediated signal transduc-
tion. These abnormalities also impair the binding ability of CCK-8 to its
receptor, thereby paralyzing gallbladder contractile function and accord-
ingly inhibiting gallbladder emptying. This change could be responsible
for signal-transduction decoupling and for impaired gallbladder contrac-
tility to CCK-8 [51].
It is hallmarked by the early appearance of biliary sludge in pregnant
women and in patients exposed to high levels of E2, showing that solid
cholesterol monohydrate crystals and microlithiasis are trapped within
mucin gel in the gallbladder. We found that the impaired gallbladder
emptying function promotes cholesterol crystallization and cholesterol
crystal growth and agglomeration into microlithiasis and stones in
E2-treated OVX ERα (+/+) mice. In contrast, this lithogenic effect of
E2, through the gallbladder ERα, on cholesterol crystallization ismarkedly
suppressed in OVX ERα (−/−) mice because gallbladder contractility is
protected and bile stasis is prevented.
We conclude that the deletion of Erα reduces susceptibility to the
formation of E2-induced gallstones by diminishing hepatic cholesterol
secretion, desaturating gallbladder bile, and improving gallbladdercontraction function in female mice (Fig. 7). Although ERα plays a crit-
ical role in the pathogenesis of E2-induced gallstones, the deletion of the
Erα gene alone cannot completely protect against gallstone formation in
mice treated with high doses of E2 and fed the lithogenic diet. Our re-
sults provide an important clue that the G protein-coupled receptor
30 (GPR30), a novel estrogen receptor, could also have a crucial effect
on the formation of E2-induced gallstones in OVX ERα (−/−) mice.
Moreover, genetic analysis in inbred mice supports the candidacy of
GPR30 for a new gallstone gene Lith18 [52–54]. Thus, identifying the
lithogenic mechanisms of GPR30 has been a focal point of interest
because it is still unknown whether GPR30 acts independently of or in
conjunctionwith ERα on inducing gallstones. The ﬁndings from the cur-
rent studies will provide a rigorous experimental framework for further
dissecting the lithogenic mechanisms between ERα and GPR30 on the
pathogenesis of E2-induced cholesterol gallstones in female mice.Conﬂict of interest
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